CASR and Familial hypocalciuric hypercalcemia type 3: Patients with familial hypocalciuric hypercalcemia type-3, a disorder due to mutations of the adaptor protein-2 (AP2) leading to defective clathrin-mediated endocytosis, have an increased expression of CaSR at the plasma membrane78.